In our study, the expression of BUB1 mRNA was significantly elevated in the central nervous system, bladder, cervical, brain, ovarian, breast, gastric, colorectal, esophageal, head, pancreatic, liver, neck, lung, and prostate cancers, as well as lymphomas and sarcomas. This evidence concerns the gene BUB1 and prostate carcinoma.